Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Vaccines × Clear all

Phase

Status

Sponsor Class

OTHER 38 INDUSTRY 15 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 337 Specimen Handling 319 Magnetic Resonance Spectroscopy 271 Radiotherapy 266 Biopsy 234 Cisplatin 218 Carboplatin 211 Doxorubicin 192 Paclitaxel 190 Fluorouracil 174 Etoposide 172 Vincristine 160 Bevacizumab 157 Filgrastim 152 Gemcitabine 141 Leucovorin 132 Cytarabine 129 aldesleukin 122 Docetaxel 104 fludarabine phosphate 99 Oxaliplatin 97 Chemotherapy, Adjuvant 97 Taxes 96 Rituximab 96 Irinotecan 90 Prednisone 89 Radiation 88 Methotrexate 88 Bortezomib 88 Peripheral Blood Stem Cell Transplantation 85

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

33 enrolled 18 charts

Adenocarcinoma, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡